SpyBiotech Appoints Seasoned Biotech Executive Mark Leuchtenberger as Chief Executive Officer

Lutz B. Giebel Ph.D.

Non Executive Chairman

Lutz is a highly experienced biotech entrepreneur with vast operational, governance and investment experience gained over 30 years' career in the United States. He has served on multiple biopharma companies Boards and overseen several successful exits.  He has held several notable positions including Managing Partner at SV Life Sciences, the international healthcare focused venture capital firm, and CEO, co-founder and Director of Delinia.  He currently serves as Chairman and Co-Founder of Implicyte and Relinia.

Prior to becoming an entrepreneur, Lutz gained a PhD in Molecular Biology from the University of Heidelberg in Germany followed by a Post-Doctorate in Human Genetics at the University of Wisconsin, Madison.

Back to team

Read more about our pipeline and the diseases we are working to eradicate.

Our Pipeline